Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.

MLA

Brouwer, Philip J. M., et al. “Potent Neutralizing Antibodies from COVID-19 Patients Define Multiple Targets of Vulnerability.” Science, vol. 369, no. 6504, Aug. 2020, pp. 643–50. EBSCOhost, https://doi.org/10.1126/science.abc5902.

APA

Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., Bentlage, A. E. H., van Haaren, M. M., Guerra, D., Burger, J. A., Schermer, E. E., Verheu, K. D., van der Velde, N., van der Kooi, A., van Schooten, J., & van Breemen, M. J. (2020). Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science, 369(6504), 643–650. https://doi.org/10.1126/science.abc5902

Chicago

Brouwer, Philip J. M., Tom G. Caniels, Karlijn van der Straten, Jonne L. Snitselaar, Yoann Aldon, Sandhya Bangaru, Jonathan L. Torres, et al. 2020. “Potent Neutralizing Antibodies from COVID-19 Patients Define Multiple Targets of Vulnerability.” Science 369 (6504): 643–50. doi:10.1126/science.abc5902.